XTX Topco’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Sell |
24,662
-191,566
| -89% | -$895K | ﹤0.01% | 1856 |
|
|
2025
Q1 | $1.19M | Buy |
+216,228
| New | +$1.19M | 0.06% | 459 |
|
|
2024
Q4 | – | Sell |
-13,890
| Closed | -$39.6K | – | 3001 |
|
|
2024
Q3 | $39.6K | Sell |
13,890
-17,892
| -56% | -$51K | ﹤0.01% | 1723 |
|
|
2024
Q2 | $71.5K | Sell |
31,782
-223,267
| -88% | -$502K | 0.01% | 1467 |
|
|
2024
Q1 | $564K | Buy |
255,049
+238,563
| +1,447% | +$527K | 0.08% | 423 |
|
|
2023
Q4 | $38.7K | Buy |
+16,486
| New | +$38.7K | 0.01% | 1276 |
|
|
2023
Q2 | – | Sell |
-233,385
| Closed | -$380K | – | 1905 |
|
|
2023
Q1 | $380K | Buy |
233,385
+44,474
| +24% | +$72.5K | 0.08% | 474 |
|
|
2022
Q4 | $251K | Buy |
+188,911
| New | +$251K | 0.05% | 701 |
|
|
2021
Q2 | – | Sell |
-10,596
| Closed | -$48K | – | 1132 |
|
|
2021
Q1 | $48K | Buy |
+10,596
| New | +$48K | 0.02% | 625 |
|